Sunshine Biopharma Inc. (SBFM): Total Assets
$30.08M
As of 2025-12-31
$33.63M
As of 2026-06-30
+0.9%
3-year compound annual growth
+95.8%
5-year compound annual growth
+46.2%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $30.08M | -1.6% | 2026-04-03, Balance as of period end |
| 2024-12-31 | $30.56M | +11.8% | 2026-04-03, Balance as of period end |
| 2023-12-31 | $27.35M | -6.5% | 2025-04-01, Balance as of period end |
| 2022-12-31 | $29.24M | n/m | 2024-03-28, Balance as of period end |
| 2021-12-31 | $2.20M | +110.7% | 2023-04-04, Balance as of period end |
| 2020-12-31 | $1.05M | +965.3% | 2022-03-21, Balance as of period end |
| 2019-12-31 | $98.1K | -91.4% | 2021-03-30, Balance as of period end |
| 2018-12-31 | $1.15M | +345.3% | 2020-05-01, Balance as of period end |
| 2017-12-31 | $257.5K | +299.8% | 2019-04-12, Balance as of period end |
| 2016-12-31 | $64.4K | -90.4% | 2018-04-02, Balance as of period end |
| 2015-12-31 | $673.3K | +369.4% | 2017-04-17, Balance as of period end |
| 2014-12-31 | $143.4K | +359.1% | 2016-03-25, Balance as of period end |
| 2013-12-31 | $31.2K | -76.8% | 2015-03-11, Balance as of period end |
| 2012-12-31 | $134.8K | +26.6% | 2014-03-19, Balance as of period end |
| 2011-12-31 | $106.4K | -48.7% | 2013-03-15, Balance as of period end |
| 2010-12-31 | $207.6K | n/a | 2012-03-19, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Sunshine Biopharma Inc. (SBFM) | 2025-12-31 | $30.08M | -1.6% |
| Lftd Partners Inc. (LIFD) | 2025-12-31 | $19.27M | -59.5% |
| Earth Science Tech, Inc. (ETST) | 2026-03-31 | $8.97M | +26.9% |
| Verrica Pharmaceuticals Inc. (VRCA) | 2025-12-31 | $47.13M | -12.9% |
| BGM Group Ltd. (BGM) | 2025-09-30 | $433.81M | +718.5% |
| Zomedica Corp. (ZOMDF) | 2025-12-31 | $127.04M | -38.7% |
| Biofrontera Inc. (BFRI) | 2025-12-31 | $28.56M | +29.2% |
| Verastem, Inc. (VSTM) | 2025-12-31 | $246.44M | +142.7% |
| Foghorn Therapeutics Inc. (FHTX) | 2025-12-31 | $198.10M | -30.2% |
Compare SBFM, LIFD, ETST, VRCA side by side · Screen every company in Pharmaceutical Preparations ↗